Neurosom Partner Company BEL Achieves FDA Goal.

Last month, BEL software SOURCERER achieved FDA 510(k) clearance. “FDA clearance of SOURCERER has been a major goal of our team and for the BEL Quality Management System,” said Dr. Don Tucker, CEO and Founder of BEL Company, and of Neurosom. BEL Company was founded in 2017 after a successful sale of a previous company […]

National Institute of Aging Awards Phase II Clinical Trial Funding for Neurosom Electric Sleep Therapy in Seniors with Mild Cognitive Impairment

Neurosom’s research partner, the Brain Electrophysiology Lab (BEL), has received $2.2 million in Phase II funding from the National Institutes of Aging to conduct an FDA-monitored clinical trial to determine if Neurosom’s Electric Sleep Therapy can improve deep sleep and memory consolidation in seniors with Mild Cognitive Impairment (MCI).   In the Phase I feasibility study, […]

Site Disclaimer

Want to learn more about investing in Regulation Crowdfunding (Reg CF)? Access our investor educational material here.

Important Disclosures

The www.RedCrow.com website (the “Website” or “Site”) is operated by Red Crow Crowd Inc. (“RedCrow”) and owned by Alira Health Transaction Services. Sections of this website are used by Alira Health Transaction Services (FINRA CRD No. 140203), which is a registered broker-dealer and a member of FINRA | SIPC. Information on all FINRA registered broker-dealers can be found on FINRA’s BrokerCheck. All securities-related activity is conducted by Alira Health Transaction Services, located at 1 Grant St, Framingham, Massachusetts 01702. Neither RedCrow or Alira Health Transaction Services provides investment advice or makes investment recommendations on this website; nothing posted on the Site should be construed as such. No communication, through this website or in any other sections of this website or medium should be construed as a recommendation for any security offered on or off this investment platform.

Alternative investments are speculative, involve a high degree of risk and are not suitable for all investors and you should not invest unless you are able to sustain the risk of loss of your entire investment. Complete loss of principal is possible. Private placements are unregistered securities, considered illiquid and long-term investments. Distributions are not guaranteed. Investing in securities involves risks, and there is always the potential of losing money when you invest in securities.

Content provided is for informational purposes only and is not intended to be an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities or a solicitation of any such offer. Information provided does not take into account an investor’s specific objectives or risk profile. Investment decisions should be made based on your objectives and circumstances and in consultation with your own advisors. Alira Health Transaction Services does not provide tax, legal or accounting advice. Please consult with and rely on a qualified professional.

By accessing this website and any pages thereof, you agree to be bound by the Terms of Use.

Form CRS | Regulation Best Interest | Business Continuity Plan | Privacy Policy | Electronic Delivery Consent.